Exploring the Frontiers of Biotech and Longevity: A Conversation with Infinita City's Niklas Anzinger

In this episode, Jason Wright interviews Niklas Anzinger, the founder of Infinita City, a pioneering biotech hub focused on accelerating breakthroughs in human health and longevity through innovative governance and community building. Niklas discusses the shortcomings of the FDA, the importance of creating novel biotech jurisdictions, and the potential for AI and digital currencies to revolutionize healthcare. The conversation also delves into the exciting vision for Infinita City and its role in transforming the future of biotech innovation.

00:00 Welcome and Introduction

00:50 Meet Nicholas: Founder of Infinite City

03:07 Nicholas' Journey and Vision

05:57 Challenges in Healthcare and Regulation

12:29 The Concept of Biohacking and Longevity

17:47 Infinite City: A Biotech Haven

21:30 The Future of Biotech and Global Hubs

26:24 Business Model and Digital Currency

31:10 Understanding Stablecoins

32:52 Residency and Membership Options

34:27 Supporting Biotech Innovators

35:55 Challenges in Drug Development

40:22 AI in Biotech Research

42:44 The Future of Longevity

47:45 Empowering Personal Health Data

51:41 Innovations in Health Insurance

54:35 Final Thoughts and Takeaways